VTRS (Viatris) Cyclically Adjusted PB Ratio: (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VTRS Viatris Inc VTRS
60 GF Score
Price $16.95
GF Value $11.42
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Viatris Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Viatris  (NAS:VTRS) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Viatris Cyclically Adjusted PB Ratio Related Terms


Viatris Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Viatris's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Viatris Cyclically Adjusted PB Ratio Chart

Viatris Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.70 0.52 0.48 0.52 0.54

Viatris Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.37 0.42 0.53 0.58 0.68

VTRS vs NBIX, UTHR, ELAN: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Viatris's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Viatris Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Viatris's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Viatris's Cyclically Adjusted PB Ratio falls into.


VTRS
60GF Score
Viatris Inc VTRS
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Viatris Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Viatris's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Viatris's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=12.344/333.9520*333.9520
=12.344

Current CPI (Jun. 2026) = 333.9520.

Viatris Quarterly Data

Book Value per Share CPI Adj_Book
201609 22.107 241.428 30.579
201612 20.768 241.432 28.727
201703 21.749 243.801 29.791
201706 23.937 244.955 32.634
201709 24.782 246.819 33.531
201712 25.386 246.524 34.389
201803 25.567 249.554 34.214
201806 23.682 251.989 31.385
201809 23.402 252.439 30.959
201812 23.589 251.233 31.356
201903 23.026 254.202 30.250
201906 23.074 256.143 30.083
201909 22.210 256.759 28.887
201912 23.024 256.974 29.921
202003 21.787 258.115 28.188
202006 22.722 257.797 29.434
202009 24.273 260.280 31.143
202012 19.019 260.474 24.384
202103 17.720 264.877 22.341
202106 17.538 271.696 21.557
202109 17.481 274.310 21.282
202112 16.943 278.802 20.295
202203 16.867 287.504 19.592
202206 16.335 296.311 18.410
202209 15.818 296.808 17.798
202212 17.361 296.797 19.534
202303 17.151 301.836 18.976
202306 17.079 305.109 18.694
202309 17.090 307.789 18.543
202312 17.045 306.746 18.557
202403 16.546 312.332 17.691
202406 16.099 314.175 17.112
202409 16.582 315.301 17.563
202412 15.612 315.605 16.520
202503 13.198 319.799 13.782
202506 13.357 322.561 13.829
202509 13.128 324.800 13.498
202512 12.779 324.054 13.169
202603 12.588 330.213 12.731
202606 12.344 333.952 12.344

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Viatris (VTRS) Overvalued in 2026?

Based on GuruFocus' analysis, Viatris stock appears to be overvalued. The current stock price of $16.95 is trading 48.4% above its estimated GF Value™ of $11.42. GuruFocus considers Viatris to be Significantly Overvalued.

Key valuation signals for VTRS:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: $11.42 vs. price of $16.95 (48.4% above fair value)
  • GF Score™: 60/100 with 8 warning signs

No single metric tells the full story. See the VTRS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Viatris Business Description

Address 1000 Mylan Boulevard, Canonsburg, PA, USA, 15317
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.
60GF Score

Get the complete analysis for VTRS

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.95
Price
$11.42
GF Value